|
|
|
Volumn 18, Issue 5 Suppl 3, 2004, Pages 16-20
|
|
Hormone- and chemotherapy-induced bone loss in breast cancer.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
AROMATASE INHIBITOR;
BISPHOSPHONIC ACID DERIVATIVE;
SELECTIVE ESTROGEN RECEPTOR MODULATOR;
BONE DENSITY;
BREAST TUMOR;
CHEMICALLY INDUCED DISORDER;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DRUG EFFECT;
FEMALE;
HUMAN;
OSTEOPOROSIS;
POSTMENOPAUSE;
PREMENOPAUSE;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
ANTINEOPLASTIC AGENTS;
AROMATASE INHIBITORS;
BONE DENSITY;
BREAST NEOPLASMS;
DIPHOSPHONATES;
FEMALE;
HUMANS;
OSTEOPOROSIS;
POSTMENOPAUSE;
PREMENOPAUSE;
RANDOMIZED CONTROLLED TRIALS;
SELECTIVE ESTROGEN RECEPTOR MODULATORS;
|
|
EID: 4344605983
PISSN: 08909091
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (19)
|
|
References (11)
|
